Sustained Release Excipients Market Report
First published: 07 October 2024 | Last updated: 28 May 2026 | Report Code: sustained-release-excipients
Sustained Release Excipients Market — USD 5.2 billion in 2023, Growing to USD 11.27B by 2033 at 7.8% CAGR
This report provides an in-depth analysis of the Sustained Release Excipients market, showcasing current market trends, forecasts for 2023-2033, and key insights into market dynamics, segmentation, and leading players within the industry.
Key Takeaways
- Global market grows from $5.20 Billion in 2023 to $11.27 Billion by 2033 at a 7.8% CAGR.
- North America is largest regional market, while no single fastest-growing region is stated because regional CAGR differences remain within 0.15 percentage points.
- Polymers, lipids, and hydrogels remain central product categories across pharmaceuticals and nutraceuticals.
- Manufacturing methods such as spheronization, extrusion, and granulation support formulation diversity and scalability.
- Leading suppliers include Evonik Industries AG, Gattefossé, Ashland Global Holdings Inc., BASF SE, and FMC Corporation.
Sustained Release Excipients Market Report — Executive Summary
North America remains largest market by forecast-period value, while no single fastest-growing region is stated because top regional growth rates are separated by less than 0.15 percentage points. This report examines sustained release excipients across product types, applications, manufacturing processes, and end-user industries. Market size expands from $5.20 Billion in 2023 to $11.27 Billion by 2033, with a compound annual growth rate of 7.8% for 2023 to 2033. Growth is driven by demand for improved drug delivery, chronic disease management, and wider use in nutraceuticals and cosmetics. Key product classes include polymers, lipids, and hydrogels, while common processes include spheronization, extrusion, and granulation. The market structure highlights pharmaceutical manufacturers as primary end users, and major suppliers such as Evonik Industries AG, Gattefossé, Ashland Global Holdings Inc., BASF SE, and FMC Corporation play significant roles in innovation and supply chains.
Key Growth Drivers
- Rising need for controlled-release formulations to improve patient adherence and therapeutic outcomes.
- Expanding applications of excipients in nutraceuticals and cosmetics alongside pharmaceuticals.
- Advancements in processing methods like spheronization, extrusion, and granulation enabling scalable production.
- Investment in R&D by manufacturers and suppliers to develop novel polymeric, lipid, and hydrogel excipients.
- Stringent quality and regulatory expectations prompting higher standards in excipient development and testing.
| Metric | Value |
|---|---|
| Study Period | 2023 - 2033 |
| 2023 Market Size | $5.20 Billion |
| CAGR (2023-2033) | 7.8% |
| 2033 Market Size | $11.27 Billion |
| Top Companies | Evonik Industries AG, Gattefossé, Ashland Global Holdings Inc., BASF SE, FMC Corporation |
| Published Date | 07 October 2024 |
| Last Modified Date | 28 May 2026 |
Sustained Release Excipients Market Overview
Customize Sustained Release Excipients Market Report market research report
- ✔ Get in-depth analysis of Sustained Release Excipients market size, growth, and forecasts.
- ✔ Understand Sustained Release Excipients's regional dynamics and industry-specific trends.
- ✔ Identify potential applications, end-user demand, and growth segments in Sustained Release Excipients
What is the Market Size & CAGR of Sustained Release Excipients Market Report market in 2023?
Sustained Release Excipients Industry Analysis
Sustained Release Excipients Market Segmentation and Scope
Tell us your focus area and get a customized research report.
Sustained Release Excipients Market Report Market Analysis Report by Region
Europe Sustained Release Excipients Market Report:
Europe grows from $1.38 Billion in 2023 to $2.99 Billion in 2033. Regional expansion is supported by regulatory focus on formulation quality, R&D efforts in drug delivery, and uptake of excipients across pharmaceuticals and nutraceuticals.Asia Pacific Sustained Release Excipients Market Report:
Asia Pacific grows from $1.05 Billion in 2023 to $2.27 Billion in 2033. Growth stems from expanding pharmaceutical manufacturing capacity, increasing chronic disease prevalence, and broader nutraceutical and cosmetic applications that leverage sustained release technologies.North America Sustained Release Excipients Market Report:
North America is largest regional market, rising from $1.88 Billion in 2023 to $4.07 Billion in 2033. Local drivers include strong pharmaceutical manufacturing activity, investment in drug-delivery R&D, and established supply chains supporting adoption of polymeric, lipid, and hydrogel excipients. North America is the largest regional market.South America Sustained Release Excipients Market Report:
Latin America grows from $0.45 Billion in 2023 to $0.99 Billion in 2033. Market progress is driven by growing pharmaceutical and dietary supplement sectors, and demand for formulations that improve dosing frequency and patient adherence.Middle East & Africa Sustained Release Excipients Market Report:
Middle East and Africa grows from $0.44 Billion in 2023 to $0.96 Billion in 2033. Drivers include rising healthcare investment, gradual growth in pharmaceutical production, and adoption of controlled-release excipients for local and regional product development.Tell us your focus area and get a customized research report.
Research Methodology
Sustained Release Excipients Market Analysis By Product Type
The by-product type segment highlights that polymers dominate the sustained release excipients market, projected to reach $7.34 billion by 2033 from $3.39 billion in 2023, holding a significant market share of 65.14%. Lipids will see growth from $1.06 billion in 2023 to $2.30 billion by 2033, maintaining a 20.36% share. Hydrogels are expected to grow from $0.75 billion to $1.63 billion, with a 14.5% share, showcasing their importance in various formulations.
Sustained Release Excipients Market Analysis By Application Area
By application area, pharmaceuticals are leading the segment with a market size of $5.64 billion by 2033, up from $2.60 billion in 2023, maintaining a share of 50.05%. Nutraceuticals will experience growth from $1.30 billion to $2.82 billion, capturing 24.99% share. Biotechnology and cosmetics will also grow steadily, holding shares of 13.04% and 11.92%, respectively.
Sustained Release Excipients Market Analysis By Manufacturing Process
The manufacturing process segment reveals that spheronization remains the leading process, projected to grow from $3.39 billion in 2023 to $7.34 billion by 2033 with a 65.14% market share. Extrusion and granulation processes are also poised for growth, with sizes of $1.06 billion (up to $2.30 billion) and $0.75 billion (up to $1.63 billion) in the same timeframe, holding shares of 20.36% and 14.5%, respectively.
Sustained Release Excipients Market Analysis By End User Industries
In terms of end-user industries, pharmaceutical manufacturers account for a substantial portion of the market, anticipated to grow from $3.39 billion in 2023 to $7.34 billion by 2033 (65.14% share). Dietary supplement manufacturers will also see an increase from $1.06 billion to $2.30 billion (20.36% share), alongside notable growth in research institutes, which will rise from $0.75 billion to $1.63 billion (14.5% share).
Sustained Release Excipients Market Trends and Future Forecast
Tell us your focus area and get a customized research report.
Global Market Leaders and Top Companies in Sustained Release Excipients Industry
Evonik Industries AG:
Evonik is a global leader in specialty chemicals, providing a broad range of excipients for the pharmaceutical industry, enhancing drug delivery systems and stability.Gattefossé:
A pioneering company in the field of excipients, Gattefossé specializes in lipids and offers advanced solutions for sustained release formulations.Ashland Global Holdings Inc.:
Ashland provides specialty chemical products and operates in various sectors, including pharmaceuticals, offering pharmaceutical excipients that enhance product performance.BASF SE:
BASF is a leading chemical company that produces a wide variety of excipients, boosting innovation in drug delivery and supporting the effective sustained release of medications.FMC Corporation:
FMC Corporation specializes in green solutions and provides a range of sustainable technologies, including excipients that support sustainable drug formulations.We're grateful to work with incredible clients.
FAQs
What is the market size of the sustained release excipients market in 2023?
The market size in 2023 is $5.20 Billion, reflecting established demand across pharmaceutical and related application areas without implying future distribution beyond provided figures.
How big will the market be in 2033?
By 2033 the market is projected to reach $11.27 Billion, based on the forecast period data provided and reflecting growth through increased formulation adoption.
What is CAGR for the forecast period?
The compound annual growth rate for the period 2023 to 2033 is 7.8%, as stated in the input data and applied across the forecast interval.
Is there a single fastest Growing region in the Sustained Release Excipients Market Report market?
No single fastest-growing region is stated for the Sustained Release Excipients Market Report market because the top regional implied CAGR values are within 0.15 percentage points of each other, making the ranking too close to call reliably.
Which product types are highlighted in the report?
The report identifies polymers, lipids, and hydrogels as primary product categories used for sustained release formulations across multiple applications.
Who are the top companies listed in the report?
Top companies named include Evonik Industries AG, Gattefossé, Ashland Global Holdings Inc., BASF SE, and FMC Corporation as leading suppliers and innovators.
What manufacturing processes are covered?
Manufacturing processes detailed include spheronization, extrusion, and granulation, which support diverse formulation requirements and production scalability.
How big is Europe’s market in 2023 and 2033?
Europe’s market grows from $1.38 Billion in 2023 to $2.99 Billion in 2033, reflecting regional demand for advanced excipients in multiple sectors.
What drives adoption in nutraceuticals and cosmetics?
Adoption is driven by formulation needs for controlled release, improved bioavailability, and expanding product portfolios that leverage excipient technology beyond pharmaceuticals.